HDAC6 is a microtubule-associated deacetylase
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Reversible acetylation of alpha-tubulin has been implicated in regulating microtubule stability and function. The distribution of acetylated alpha-tubulin is tightly controlled and stereotypic. Acetylated alpha-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts. However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known. Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase. HDAC6 is localized exclusively in the cytoplasm, where it associates with microtubules and localizes with the microtubule motor complex containing p150(glued) (ref. 3). In vivo, the overexpression of HDAC6 leads to a global deacetylation of alpha-tubulin, whereas a decrease in HDAC6 increases alpha-tubulin acetylation. In vitro, purified HDAC6 potently deacetylates alpha-tubulin in assembled microtubules. Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility. Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC6 catalyzes the deacetylation of K40 in the α-tubulin subunit of the microtubule,24 thereby regulating microtubule dynamics”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [24]
In the citing paper
“HDAC6, a tubulin deacetylase [24].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [24]
In the citing paper
“The histone deacetylase 6 (HDAC6) has also been implicated in tau deacetylation/acetylation [180].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [180]
In the citing paper
“HDAC6 was shown to be the deacetylase for a diverse set of substrates involved in tumourigenesis, such as HSP90, α-tubulin, cortactin and peroxiredoxins”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
In the citing paper
“HDAC6 knockout in mice does not lead to embryonic lethality”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770 · cited 1×
“At least 11 proteins predicted to be members of the HDAC family have been identified on the basis of homology within the catalytic domai”
BackgroundPiperno, G., & Fuller, M. T. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.6.2085 · Cited by 757
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
Self-citationMicrotubule Targeting of Substrate Contacts Promotes Their Relaxation and Dissociation
Kaverina, I., Krylyshkina, O., & Small, J. V. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.1033 · Cited by 480
Histone acetylation: chromatin in action
Wade, P. A., Pruss, D., & Wolffe, A. P. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01016-5 · Cited by 471
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412 · cited 1×
“Unlike other family members, HDAC6 is uniquely resistant to the potent HDAC inhibitors trapoxin-B (TPXb”
BackgroundSelf-citationRegulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1
Smith, D. S., Niethammer, M., Ayala, R., Zhou, Y., Gambello, M. J., Wynshaw-Boris, A., & Tsai, L.-H. (2000) · Nature Cell Biology · doi:10.1038/35041000 · Cited by 381
Cited by
Items 701–800 of 1,012
Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation
Carmona, B., Marinho, H. S., Matos, C. L., Nolasco, S., & Soares, H. (2023) · Biology · doi:10.3390/biology12040561 · Cited by 74
“Despite this interaction, HDAC6 and SIRT2 are able to individually catalyze the deacetylation of α-tubulin, in vitro and in vivo [148,204,206,231].”
BackgroundInfluentialDiphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors
Tessier, P., Smil, D. V., Wahhab, A., Leit, S. M., Rahil, J. F., Li, Z., Déziel, R., & Besterman, J. M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.010 · Cited by 65
Nagai, T., Ikeda, M., Chiba, S., Kanno, S., & Mizuno, K. (2013) · Journal of Cell Science · doi:10.1242/jcs.127209 · Cited by 63
Dual-acting histone deacetylase-topoisomerase I inhibitors
Guerrant, W., Patil, V., Canzoneri, J. C., Yao, L.-P., Hood, R., & Oyelere, A. K. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.108 · Cited by 58
Cystathionine γ-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6
Leucker, T. M., Nomura, Y., Kim, J. H., Bhatta, A., Wang, V. C., Wecker, A., Jandu, S., Santhanam, L., Berkowitz, D. E., Romer, L. H., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00724.2016 · Cited by 64
HDAC6 Restricts Influenza A Virus by Deacetylation of the RNA Polymerase PA Subunit
Chen, H., Qian, Y., Chen, X., Ruan, Z., Ye, Y., Chen, H., Babiuk, L. A., Jung, Y., & Dai, J. (2018) · Journal of Virology · doi:10.1128/jvi.01896-18 · Cited by 59
Multiple Histone Deacetylases and the CREB-binding Protein Regulate Pre-mRNA 3′-End Processing
Shimazu, T., Horinouchi, S., & Yoshida, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609745200 · Cited by 59
Self-citationOnishi, T., Maeda, R., Terada, M., Sato, S., Fujii, T., Ito, M., Hashikami, K., Kawamoto, T., & Tanaka, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-94923-w · Cited by 63
Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
Frühauf, A., & Meyer‐Almes, F. (2021) · Molecules · doi:10.3390/molecules26175151 · Cited by 62
“Typical substrates of interest are acetylated histones, which are preferred substrates of HDACs 1, 2, and 3, acetylated α-tubulin, a specific substrate for HDAC6 [51], and acetylated SMC3, which is a bona fide substrate of HDAC8 [52].”
BackgroundThe molecular mechanism, targets, and novel molecules in the treatment of Alzheimer’s disease
Verma, A., Waiker, D. K., Bhardwaj, B., Saraf, P., & Shrivastava, S. K. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105562 · Cited by 60
Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
Chotitumnavee, J., Yamashita, Y., Takahashi, Y., Takada, Y., Iida, T., Oba, M., Itoh, Y., & Suzuki, T. (2022) · Chemical Communications · doi:10.1039/d2cc00272h · Cited by 59
The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation
Valera, M.-S., de Armas‐Rillo, L., González, J. B., Ziglio, S., Batisse, J., Dubois, N., Marrero‐Hernández, S., Borel, S., García-Expósito, L., Biard‐Piechaczyk, M., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0181-5 · Cited by 64
“Concerning the A3G/HDAC6 interaction, we observed that A3G interacted with any of the HDAC6 constructs used in our study (Figure 6e), containing or not the BUZ domain, the BUZ domain alone or a dead-mutant (dm) HDAC6 protein which harbours a double point mutation (H216A/H611A) inactivating deacetylation [44, 55, 65].”
BackgroundHdac-Mediated Control of Endochondral and Intramembranous Ossification
Westendorf, J. J., Bradley, E. W., & McGee‐Lawrence, M. E. (2011) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v21.i2.10 · Cited by 73
Jochems, J., Teegarden, S. L., Chen, Y., Boulden, J., Challis, C., Ben-Dor, G. A., Kim, S. F., & Berton, O. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.036 · Cited by 58
Wilson, P. M., El-Khoueiry, A. B., Iqbal, S., Fazzone, W., LaBonte, M. J., Groshen, S. G., Yang, D., Danenberg, K. D., Cole, S., Kornacki, M., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1236-x · Cited by 61
Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity
Han, Y., Jeong, H. M., Jin, Y.-H., Kim, Y.-J., Jeong, H. G., Yeo, C., & Lee, K.-Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.147 · Cited by 61
“This suggests that, through reversible acetylation, HDACs can regulate other important biological processes beside chromatin remodeling and gene transcription [4,5].”
BackgroundMoriya, S., KOMATSU, S., Yamasaki, K., KAWAI, Y., Kokuba, H., Hirota, A., Che, X., Inazu, M., Gotoh, A., Hiramoto, M., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2773 · Cited by 61
Insights into the lysine acetylproteome of human sperm
Sun, G.-H., Jiang, M., Zhou, T., Guo, Y., Cui, Y., Guo, X., & Sha, J. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.07.002 · Cited by 65
“[10] Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al.”
BackgroundHDACs class II-selective inhibition alters nuclear receptor-dependent differentiation
Nebbioso, A., Dell’Aversana, C., Bugge, A. K., Sarno, R., Valente, S., Rotili, D., Manzo, F., Teti, D. V., Mandrup, S., Ciana, P., et al. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0043 · Cited by 66
Scott, G. K., Marx, C., Berger, C. E., Saunders, L. R., Verdin, E., Schäfer, S., Jung, M., & Benz, C. C. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2110 · Cited by 58
“previous studies have shown that HDAC6 is the primary source of most cytoplasmic HDAC enzymatic activities (10-13), Western analysis of HuR immunoprecipitates confirmed the”
BackgroundXu, J., Yang, J., Nyga, A., Ehteramyan, M., Moraga, A., Wu, Y., Zeng, L., Knight, M. M., & Shelton, J. C. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.054 · Cited by 59
“a-tubulin, hence promoting cell chemotactic migration [23].”
BackgroundKarki, P., Ke, Y., Tian, Y., Ohmura, T., Sitikov, A. S., Sarich, N. A., Montgomery, C. P., & Birukova, A. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004030 · Cited by 59
Microtubules are more stable and more highly acetylated in ethanol-treated hepatic cells
Kannarkat, G. T., Tuma, D. J., & Tuma, P. L. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.007 · Cited by 63
“In contrast, when the enzymes are inactivated by pharmacological agents or their expression is knocked down, microtubules are more stable and hyperacetylated up to five-fold [28–31].”
BackgroundLiu, A., Muggironi, M., Marin‐Husstege, M., & Casaccia‐Bonnefil, P. (2003) · Glia · doi:10.1002/glia.10290 · Cited by 58
“It has been recently proposed that the effect of TSA on the morphology of tumor cell line is mediated by the inhibition of HDAC-6, which is responsible for deacetylation of -tubulin (Hubbert et al., 2002; Zhang et al., 2003).”
BackgroundChi, Z., Byeon, H.-E., Seo, E., Nguyen, Q.-A. T., Lee, W., Jeong, Y., Choi, J., Pandey, D., Berkowitz, D. E., Kim, J. H., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104281 · Cited by 59
Posttranslational modifications of the cytoskeleton
MacTaggart, B., & Kashina, A. S. (2021) · Cytoskeleton · doi:10.1002/cm.21679 · Cited by 65
“, 2010; Shida, Cueva, Xu, Goodman, & Nachury, 2010) HDAC6 (Hubbert et al., 2002), SIRT2 (North, Marshall, Borra, Denu, & Verdin, 2003) • Makes microtubules more flexible and resistant to mechanical breakage in vitro and in cells (Eshun-Wilson et al.”
BackgroundInfluentialSreenivasmurthy, S. G., Iyaswamy, A., Krishnamoorthi, S., Senapati, S., Malampati, S., Zhu, Z., Su, C.-F., Liu, J., Guan, X.-J., Tong, B. C., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153887 · Cited by 63
Role of stress granules in tumorigenesis and cancer therapy
Li, T., Zeng, Z., Fan, C., & Xiong, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189006 · Cited by 64
Histone deacetylases and their role in motor neuron degeneration
Lazo-Gómez, R., Ramírez-Jarquín, U. N., Tovar-y-Romo, L. B., & Tapia, R. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00243 · Cited by 57
“HDAC6 is an unusual enzyme, in the sense that it has two catalytic domains and functions in the cytoplasm where it deacetylates α-tubulin and alters microtubule stability (Hubbert et al., 2002).”
BackgroundInfluentialPrimary cilium: an elaborate structure that blocks cell division?
Ke, Y., & Yang, W. (2014) · Gene · doi:10.1016/j.gene.2014.06.050 · Cited by 73
“Histone deacetylase 6 (HDAC6) and sirtuin type 2 (SIRT2) function as tubulin deacetylases, co-localize with each other, and interact with the microtubule network (Hubbert et al., 2002; North et al., 2003).”
BackgroundFunction of Sirtuins in Biological Tissues
Shoba, B., Lwin, Z. M., Ling, L. S., Bay, B., Yip, G. W., & Kumar, S. D. (2009) · The Anatomical Record · doi:10.1002/ar.20875 · Cited by 57
“SIRT2 mainly deacetylates a-tubulin, which co-localizes with microtubules and HDAC6 (Hubbert et al., 2002; North et al., 2003; Zhang et al., 2003).”
BackgroundZach, F., Graßmann, F., Langmann, T., Sorusch, N., Wolfrum, U., & Stöhr, H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds268 · Cited by 67
“HDAC6, aTAT1) (33,34) as was shown for other proteins like TPPP/p25 or dysferlin (35,36).”
BackgroundRui, Y., & Zheng, J. Q. (2016) · Molecular Brain · doi:10.1186/s13041-016-0261-z · Cited by 57
“HDAC6 is a member of class II HDACs that is localized mostly in the cytoplasm with a preference for non-histone proteins [46].”
BackgroundMa, J., Trinh, R. T. P., Mahant, I., Peng, B., Matthias, P., Heijnen, C. J., & Kavelaars, A. (2019) · Pain · doi:10.1097/j.pain.0000000000001667 · Cited by 60
“towards histones, but mainly targets cytosolic proteins such as a-tubulin.(3,16,21) HDAC6 has been implicated in the pathogenesis of neurodegenerative diseases as well as cancer.”
BackgroundJiang, Q., Ren, Y., & Feng, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2860-08.2008 · Cited by 57
“HDAC6 and parkin directly binds to each other through multiple interaction domains Both parkin and HDAC6 normally associate with microtubules (Hubbert et al., 2002; Ren et al., 2003) and become accumulated in the centrosome in response to proteasomal inhibition (Kawaguchi et al., 2003; Zhao et al.,…”
InfluentialHistone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
Sandonà, M., Cavioli, G., Renzini, A., Cedola, A., Gigli, G., Coletti, D., McKinsey, T. A., Moresi, V., & Saccone, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054306 · Cited by 65
König, B., Watson, P. R., Reßing, N., Cragin, A. D., Schäker‐Hübner, L., Christianson, D. W., & Hansen, F. K. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01345 · Cited by 58
IIp45 Inhibits Cell Migration through Inhibition of HDAC6
Wu, Y., Song, S. W., Sun, J., Bruner, J. M., Fuller, G. N., & Zhang, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063354 · Cited by 60
HDAC6 as a target for antileukemic drugs in acute myeloid leukemia
Hackanson, B. W., Rimmele, D. L., Benkißer-Petersen, M., Abdelkarim, M., Fliegauf, M., Jung, M., & Lübbert, M. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.02.026 · Cited by 57
Explorative Study on Isoform-Selective Histone Deacetylase Inhibitors
Suzuki, T. (2009) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.57.897 · Cited by 63
Lucas, D. M., Alinari, L., West, D. A., Davis, M. E., Edwards, R. B., Johnson, A. J., Blum, K. A., Hofmeister, C. C., Freitas, M. A., Parthun, M. R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010941 · Cited by 60
“These include aggresome formation [30], motility [31], and cytotoxicity in EBV-positive lymphoma cells [32].”
BackgroundDhakal, B. K., & Mulvey, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805010200 · Cited by 62
IKAP/Elp1 involvement in cytoskeleton regulation and implication for familial dysautonomia
Cheishvili, D., Maayan, C., Cohen-Kupiec, R., Lefler, S., Weil, M., Ast, G., & Razin, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr036 · Cited by 62
Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2
Jayathilaka, N., Han, A., Gaffney, K. J., Dey, R., Jarusiewicz, J. A., Noridomi, K., Philips, M. A., Lei, X., He, J., Ye, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks189 · Cited by 56
“The MEF2A (1–78)/BML-210/DNA complex was prepared in two steps.”
BackgroundMethodInfluentialInvestigating Tubulin Posttranslational Modifications with Specific Antibodies
Magiera, M. M., & Janke, C. (2013) · Methods in cell biology · doi:10.1016/b978-0-12-407757-7.00016-5 · Cited by 68
Majora, M., Sondenheimer, K., Knechten, M., Uthe, I., Esser, C., Schiavi, A., Ventura, N., & Krutmann, J. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7510 · Cited by 57
Souphron, J., Bodakuntla, S., Jijumon, A. S., Lakisic, G., Gautreau, A. M., Janke, C., & Magiera, M. M. (2019) · Nature Protocols · doi:10.1038/s41596-019-0153-7 · Cited by 69
Osko, J. D., Porter, N. J., Narayana Reddy, P. A., Xiao, Y.-C., Rokka, J., Jung, M., Hooker, J. M., Salvino, J. M., & Christianson, D. W. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01540 · Cited by 53
Microtubules in Influenza Virus Entry and Egress
Simpson, C., & Yamauchi, Y. (2020) · Viruses · doi:10.3390/v12010117 · Cited by 60
“A number of enzymes regulate the reversible acetylation of tubulin: The acetyltransferases ARD1-NAT1, ELP3, San, and αTAT1 [8–13], and the deacetylases histone deacetylase 6 (HDAC6) and SirT2 [14,15].”
BackgroundRequirement of histone deacetylase activity for the expression of critical photoreceptor genes
Chen, B., & Cepko, C. L. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-78 · Cited by 60
“HDAC6 deacetylates α-tubulin, with a resulting increase in cell motility [11].”
BackgroundHistone Deacetylation as a Target for Radiosensitization
Cerna, D., Camphausen, K. A., & Tofilon, P. J. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)73006-4 · Cited by 57
Intrinsic and Extrinsic Factors Affecting Microtubule Dynamics in Normal and Cancer Cells
Borys, F., Joachimiak, E., Krawczyk, H., & Fabczak, H. (2020) · Molecules · doi:10.3390/molecules25163705 · Cited by 60
“The modification is reversible, and tubulin deacetylation is carried out by histone deacetylase 6 (HDAC6) [94] and Sirt2 deacetylase [95].”
BackgroundMechanical confinement governs phenotypic plasticity in melanoma
Hunter, M. V., Joshi, E., Bowker, S., Montal, E. D., Ma, Y., Kim, Y. H., Yang, Z., Tuffery, L., Li, Z., Rosiek, E., et al. (2025) · Nature · doi:10.1038/s41586-025-09445-6 · Cited by 70
FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70
Wang, Y., Wang, S., Zhang, X., Zhao, M., Hou, C., Xu, Y.-J., Du, Z., & Yu, X. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.076 · Cited by 59
Acetylation of Heat Shock Protein 20 (Hsp20) Regulates Human Myometrial Activity
Karolczak-Bayatti, M., Sweeney, M., Cheng, J., Edey, L., Robson, S. C., Ulrich, S. M., Treumann, A., Taggart, M. J., & Europe-Finner, G. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278549 · Cited by 55
Strobl, J. S., Nikkhah, M., & Agah, M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.023 · Cited by 60
“While others have documented that inhibition of HDAC6 results in alpha-tubulin protein acetylation [42], we showed that the microtubule network in MDA-MB-231 cells is subject to regulation by SAHA resulting in a highly developed web of fibers emanating from the microtubule organizing center (Fig.”
BackgroundSamartzis, E. P., Noske, A., Samartzis, N., Fink, D. A., & Imesch, P. (2013) · Reproductive Sciences · doi:10.1177/1933719113488450 · Cited by 61
Barcellos, K. S. A., Bigarella, C. L., Wagner, M. V., Vieira, K. P., Lazarini, M., Langford, P. R., Machado‐Neto, J. A., Call, S. G., Staley, D. M., Chung, J. Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432716 · Cited by 57
“A member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase, and HDAC6 is localized exclusively in the cytoplasm (35).”
BackgroundHDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Putcha, P., Yu, J., Barrueco, R. R., Saucedo-Cuevas, L. P., Villagrasa, P., Murga-Penas, E., Quayle, S. N., Yang, M., Castro, V., Llobet‐Navàs, D., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0658-0 · Cited by 58
“In this aspect, HDAC6 [18, 20, 44] was also especially interesting, as it represents a druggable target with highly selective inhibitors [21, 45] already available in”
BackgroundTseng, H.-J., Lin, M.-H., Shiao, Y.-J., Yang, Y.-C., Chu, J.-C., Chen, C.-Y., Chen, Y.-Y., Lin, T. E., Su, C.-J., Pan, S.-L., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112193 · Cited by 53
HDAC Inhibitors and Cancer Therapy
Atadja, P. W. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_9 · Cited by 62
“In a bid to identify the HDAC isoform (s) that regulate microtubule function, yeast two hybrid and biochemical techniques were applied to identify HDAC6 as the major tubulin deacetylase [ 33 , 34].”
MethodMuraglia, E., Altamura, S., Branca, D., Cecchetti, O., Ferrigno, F., Orsale, M. V., Palumbi, M. C., Rowley, M., Scarpelli, R., Steinkühler, C., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.076 · Cited by 56
The Centrosome in Normal and Transformed Cells
Wang, Q., Hirohashi, Y., Furuuchi, K., Zhao, H., Liu, Q., Zhang, H., Murali, R., Berezov, A., Du, X., Li, B., et al. (2004) · DNA and Cell Biology · doi:10.1089/1044549041562276 · Cited by 61
Piracha, Z. Z., Saeed, U., Kim, J., Kwon, H., Chwae, Y., Lee, H. W., Lim, J. H., Park, S., Shin, H., & Kim, K. H. (2020) · Journal of Virology · doi:10.1128/jvi.00926-20 · Cited by 60
“HDAC6, an exclusively cytoplasmic protein (49) that cannot be recruited to cccDNA, was used as a negative control (Fig.”
MethodGold, W. A., Lacina, T. A., Cantrill, L. C., & Christodoulou, J. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1202-x · Cited by 55
“HDAC6 and SIRT2 are unique HDACs in that they catalyse α-tubulin deacetylation.”
InfluentialEpigenetic control of gene function in schistosomes: a source of therapeutic targets?
Cabezas‐Cruz, A., Lancelot, J., Caby, S., Oliveira, G., & Pierce, R. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00317 · Cited by 56
The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer
Gridelli, C., Rossi, A., & Maione, P. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.03.002 · Cited by 54
The therapeutic uses of chromatin-modifying agents
Mai, A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.6.835 · Cited by 61
“However, class IIb HDAC6 takes part, together with the class III HDAC SIRT2, in the microtubule network and acts as specific α-tubulin deacetylase in vitro and in vivo [15].”
BackgroundStem cell-derived motor neurons from spinal and bulbar muscular atrophy patients
Grunseich, C., Zukosky, K., Kats, I. R., Ghosh, L., Harmison, G. G., Bott, L. C., Rinaldi, C., Chen, K., Chen, G., Boehm, M., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.038 · Cited by 54
“Stacking gel analysis for aggregation analysis was performed on supernatant samples prepared after centrifugation at 4 °C for 10 min at 425 g. PNGaseF was purchased from New England Biolabs (Ipswich,MA), and treatmentswere performed for 3 h using the manufacturer's guidelines.”
MethodYang, W., Guo, X., Thein, S., Xu, F., Sugii, S., Baas, P. W., Radda, G. K., & Han, W. (2012) · Biochemical Journal · doi:10.1042/bj20121121 · Cited by 62
Hsu, K., Liu, C., Lin, T. E., Hsieh, J.-H., Sung, T.-Y., Tseng, H.-J., Yang, J., & Huang, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-03417-1 · Cited by 60
ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types
Chüeh, A. C., Tse, J. W. T., Dickinson, M. J., Ioannidis, P., Jenkins, L. J., Tögel, L., Tan, B., Luk, I. Y., Dávalos-Salas, M., Nightingale, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0466 · Cited by 57
“In addition, HDACi can elicit cellular effects independent of transcription by acetylating cytoplasmic proteins such as Hsp90 and tubulin (9,10).”
Pool, L., Wijdeveld, L. F. J. M., de Groot, N. M. S., & Brundel, B. J. J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168463 · Cited by 56
Yang, J., Grafton, F., Ranjbarvaziri, S., Budan, A., Farshidfar, F., Cho, M., Xu, E., Ho, J. J., Maddah, M., Loewke, K. E., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl5654 · Cited by 57
“Tubulin is a known substrate for HDAC6, and Ac-Tubulin is a posttranslational modification used as a pharmacodynamic marker of HDAC6 activity (27).”
BackgroundInfluentialGardiner, J. C., Barton, D., Marc, J., & Overall, R. L. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00605.x · Cited by 61
“In fact, a member of the histone deacetylase family, histone deacetylase 6, also acts as a tubulin deacetylase (8).”
BackgroundViral–Host Interactions That Control HIV-1 Transcriptional Elongation
Lu, H., Li, Z., Xue, Y., & Zhou, Q. (2013) · Chemical Reviews · doi:10.1021/cr400120z · Cited by 62
Nakakura, T., Asano-Hoshino, A., Suzuki, T., Arisawa, K., Tanaka, H., Sekino, Y., Kiuchi, Y., Kawai, K., & Hagiwara, H. (2014) · Medical Molecular Morphology · doi:10.1007/s00795-014-0076-x · Cited by 56
“Histone deacetylase 6 (HDAC6) is recently identified as a cytoplasmic enzyme for the deacetylation of lysine residues in a-tubulin [52, 53].”
BackgroundChen, Y., Chen, Y., Chiu, W., Liu, K.-Y., Liu, Y.-L., Chang, J., Chang, H., & Shen, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4127 · Cited by 59
“Cancer Res; 73(14) July 15, 2013 Cancer Research OF6”
BackgroundInfluentialMao, C., Xiong, Y., Xiong, Z., Wang, Q., Zhang, Y., & Jin, S. (2014) · Development · doi:10.1242/dev.097774 · Cited by 61
“HDAC6 deacetylates MTs in both mammals and Drosophila (Hubbert et al., 2002; Matsuyama et al., 2002; Sudo and Baas, 2010; Xiong et al., 2013).”
BackgroundKuhlmann, N., Wroblowski, S., Knyphausen, P., de Boor, S., Brenig, J., Zienert, A. Y., Meyer-Teschendorf, K., Praefcke, G. J. K., Nolte, H., Krüger, M., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707091 · Cited by 53
The growing landscape of tubulin acetylation: lysine 40 and many more
Sadoul, K., & Khochbin, S. (2016) · Biochemical Journal · doi:10.1042/bcj20160172 · Cited by 58
Ganai, S. A. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.130 · Cited by 53
Cosenza, M., Civallero, M., Marcheselli, L., Sacchi, S., & Pozzi, S. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1364-4 · Cited by 54
“One non histone target for HDAC6 is tubulin [45].”
BackgroundHistone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
Mrakovcic, M., Kleinheinz, J., & Fröhlich, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091883 · Cited by 51
“HDAC6 was identified as a microtubule-associated deacetylase that interacts with polyubiquitinated proteins [186,195].”
BackgroundMoreno-Gonzalo, O., Ramírez‐Huesca, M., Blas‐Rus, N., Cibrián, D., Sáiz, M. L., Jorge, I., Camafeita, E., Vázquez, J., & Sánchez‐Madrid, F. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006799 · Cited by 56
Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines
Keremu, A., Aimaiti, A., Liang, Z., & Zou, X. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3721-6 · Cited by 54
Bardet–Biedl Syndrome proteins regulate cilia disassembly during tissue maturation
Patnaik, S. R., Kretschmer, V., Brücker, L., Schneider, S., Volz, A., Oancea-Castillo, L., & May‐Simera, H. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2966-x · Cited by 51
Targeting HDAC Complexes in Asthma and COPD
Zwinderman, M. R. H., de Weerd, S., & Dekker, F. J. (2019) · Epigenomes · doi:10.3390/epigenomes3030019 · Cited by 52
“Tubulin is a major component of the cytoskeleton and is thereby involved in cell motility [85,86].”
BackgroundZheng, Z., Zhou, Y., Ye, L., Lu, Q., Zhang, K., Zhang, J., Xie, L., Wu, Y., Xu, K., Zhang, H., et al. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113138 · Cited by 54
Yagi, Y., Fushida, S., Harada, S., Kinoshita, J., Makino, I., Oyama, K., Tajima, H., Fujita, H., Takamura, H., Ninomiya, I., et al. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-149 · Cited by 61
“HDAC inhibitors also play a role as microtubule-associated deacetylases and cause acetylation of lysine40 of a-tubulin [44,45].”
BackgroundHistone deacetylase 6 gates the synaptic action of acute stress in prefrontal cortex
Lee, J. B., Wei, J., Liu, W., Cheng, J., Feng, J., & Yan, Z. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224907 · Cited by 52
“When confronted with stress, the brain activates many neural networks and hormonal mediators to adapt to the disturbance (McEwen, 2007; Joëls & Baram, 2009).”
BackgroundMcAlpin, B. R., Mahalingam, R., Singh, A. K., Dharmaraj, S., Chrisikos, T. T., Boukelmoune, N., Kavelaars, A., & Heijnen, C. J. (2021) · Theranostics · doi:10.7150/thno.67410 · Cited by 53
“As a cytoplasmic enzyme, HDAC6 does not interact directly with histones; its main substrates include heat shock protein 90 (HSP90) and α-tubulin, involved in protein folding and intracellular transport, respectively [19].”
BackgroundRETRACTED ARTICLE: Human HDAC6 senses valine abundancy to regulate DNA damage
Jin, J., Meng, T., Yu, Y., Wu, S., Jiao, C., Song, S., Li, Y., Zhang, Y., Zhao, Y.-Y., Li, X., et al. (2024) · Nature · doi:10.1038/s41586-024-08248-5 · Cited by 57
“HDAC6, a class IIb histone deacetylase, is mainly localized in the cyto-plasm to regulate tubulin acetylation and mTOR signalling 18,19 .”
RetractedChronic inflammation and vascular cell plasticity in atherosclerosis
Lin, A., Miano, J. M., Fisher, E. A. A., & Misra, A. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00569-y · Cited by 64
“HDAC6 may be particularly interesting for atherosclerosis in the context of colchicine’s cardiovascular success, as HDAC6 also regulates micro-tubule dynamics 160 .”
Wilson, A. J., Holson, E. B., Wagner, F. F., Zhang, Y.-L., Fass, D. M., Haggarty, S. J., Bhaskara, S., Hiebert, S. W., Schreiber, S. L., & Khabele, D. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.6.15956 · Cited by 58
p97/valosin‐containing protein (VCP) is highly modulated by phosphorylation and acetylation
Konya, C., Kato, N., Maeda, R., Yasuda, K., Higashimae, N., Noguchi, M., Koike, M., Kimura, Y., Ohizumi, H., Hori, S., et al. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01286.x · Cited by 59
“Interestingly, acetylated α-tubulin has been shown to be deacetylated by HDAC6 (Hubbert et al. 2002; Matsuyama et al. 2002; Zhang et al. 2003), and HDAC6 and VCP have been reported to physically interact each other (SeigneurinBerny et al. 2001).”
BackgroundInfluentialLoss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma
Birnie, K. A., Yip, Y. Y., Ng, D. C. H., Kirschner, M. B., Reid, G., Prêle, C. M., Musk, A. W., Lee, G., Thompson, P. J., Mutsaers, S. E., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0442 · Cited by 56
“In support of the observed reduction in cell motility, overexpressing miR-223 induced the acetylation of tubulin within MPM cells The acetylation of tubulin is consistent with microtubule stabilisation and a reduction in cell motility (48).”
BackgroundHDAC6: Physiological function and its selective inhibitors for cancer treatment
Yang, P. (2013) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2013.v7.6.233 · Cited by 56
“Some structurally diverse compounds have been considered as HDACS inhibitors, such as TSA (trichostatin A, 3), SAHA (suberoylanilide hydroxamic acid, 4), CHAP31 (1), TPXB (trapoxin B, 2), and MS275 (5) (Figure 2).”
BackgroundA patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations
Abrahamsen, G., Fan, Y., Matigian, N., Wali, G., Bellette, B., Sutharsan, R., Raju, J., Wood, S. A., Veivers, D., Sue, C. M., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010884 · Cited by 58
“…a window into microtubule dynamics, we quantified levels of post-translational modifications to α-tubulin: stabilized microtubules become acetylated, tyrosination assists turnover and de-tyrosination assists stability (Hubbert et al., 2002; Kreis, 1987; Piperno et al., 1987; Webster et al., 1987).”
Epigenetics and autosomal dominant polycystic kidney disease
Li, X. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.008 · Cited by 56
“In the transcription-independent mechanism, HDACs regulate specific cellular functions through deacetylation of a number of cytoplasmic proteins, such as tubulin [44] and HSP90 [45], which are the substrates of HDAC6.”
Metadata
- Authors
- Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P.
- Affiliations
- Duke University (US)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Yao, Tso-Pang
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6887
- Pages
- 455-458
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2064959533
- Cited by
- 2,403
- References
- 21
- Citations by year
- 2026: 96 · 2025: 116 · 2024: 116 · 2023: 126 · 2022: 117 · 2021: 139 · 2020: 130 · 2019: 122 · 2018: 112 · 2017: 102 · 2016: 102 · 2015: 117 · 2014: 119 · 2013: 117 · 2012: 122
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Defense
- Damon Runyon Cancer Research Foundation
- World Bank Group
- Robert Bosch Stiftung
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HDAC6, alpha-tubulin acetylation, microtubule stability, p150Glued, cell motility, chemotaxis, histone deacetylase
- MeSH terms
- Histone Deacetylase 6, Acetylation, Animals, Chemotaxis, Histone Deacetylases, Microtubule-Associated Proteins, Microtubules, Protein Binding, Tubulin, 3T3 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.